Showing results (921-930 of 1,073) with videos related to

Sort By:
Pageof 108
Cardiovascular Therapeutics|January 8, 2014
Cardiovascular medication use following percutaneous coronary intervention: the Australian experienceJustin A Cole, Angela L Brennan, Andrew E Ajani, et al.
The Journal of Clinical Investigation|May 3, 2014
Endothelial HIF-2 mediates protection and recovery from ischemic kidney injuryPinelopi P Kapitsinou, Hideto Sano, Mark Michael, et al.
International Journal of Cardiology|May 7, 2013
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registryThathya V Ariyaratne, Zanfina Ademi, Stephen J Duffy, et al.
The American Journal of Cardiology|May 13, 2017
Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)Julian Yeoh, Matias B Yudi, Nick Andrianopoulos, et al.
Journal of Pain Research|June 6, 2017
Quantitative sensory testing measures individual pain responses in emergency department patientsKevin J Duffy, Katharyn L Flickinger, Jeffrey T Kristan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 5, 2020
Outcomes of cardiogenic shock complicating acute coronary syndromesSamer Noaman, Nick Andrianopoulos, Angela L Brennan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 23, 2020
Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary interventionSamer Noaman, Jessica O'Brien, Nick Andrianopoulos, et al.
JACC. Cardiovascular Interventions|April 22, 2022
Percutaneous Coronary Intervention Volume and Cardiac Surgery Availability Effect on Acute Coronary Syndrome-Related Cardiogenic ShockSamer Noaman, Sara Vogrin, Diem Dinh, et al.
Stem Cells (Dayton, Ohio)|November 29, 2008
Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonistConnie L Erickson-Miller, Evelyne Delorme, Shin-Shay Tian, et al.
Journal of Veterinary Internal Medicine|August 10, 2019
Clinical findings, diagnostic test results, and treatment outcome in cats with hiatal hernia: 31 cases (1995-2018)Heidi Phillips, Jessica Corrie, Danielle M Engel, et al.
Pageof 108